Publications searcher The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Role of biomarkers in early infectious complications after lung transplantation. PMID: 28704503 Journal: PLoS One Year: 2017 Reference: PLoS One. 2017 Jul 13;12(7):e0180202. doi: 10.1371/journal.pone.0180202. eCollection 2017. Impact factor: Publication type: Paper in international publication Authors: Garcia Campos, Ascension; Iranzo, Reyes; Minambres, Eduardo; Rellan, Luzdivina; Riera, Jordi; Robles, Juan Carlos; Santibanez, Miguel; Suberviola, Borja; Vicente, Rosario et al. DOI: 10.1371/journal.pone.0180202 Role of intraluminal bowel echogenicity on prenatal ultrasounds to determine the anatomical level of intestinal atresia. PMID: 27023781 Journal: Journal of Maternal-Fetal & Neonatal Medicine Year: 2017 Reference: J Matern Fetal Neonatal Med. 2017 Jan;30(1):103-108. doi: 10.3109/14767058.2016.1163677. Epub 2016 Mar 29. Impact factor: 1.674 Publication type: Paper in international publication Authors: Goruppi, Ilaria, Arevalo, Silvia, Gander, Romy, Molino, Jose-Andres, Oria, Marc, Carreras, Elena, Peiro, Jose-Luis et al. DOI: 10.3109/14767058.2016.1163677 Role of intraluminal bowel echogenicity on prenatal ultrasounds to determine the anatomical level of intestinal atresia. PMID: 27023781 Journal: Journal of Maternal-Fetal & Neonatal Medicine Year: 2017 Reference: J Matern Fetal Neonatal Med. 2017 Jan;30(1):103-108. doi: 10.3109/14767058.2016.1163677. Epub 2016 Mar 29. Impact factor: Publication type: Paper in international publication Authors: Arevalo, Silvia; Carreras, Elena; Gander, Romy; Goruppi, Ilaria; Molino, Jose-Andres; Oria, Marc; Peiro, Jose-Luis et al. DOI: 10.3109/14767058.2016.1163677 Role of Parp Activity in Lung Cancer-induced Cachexia: Effects on Muscle Oxidative Stress, Proteolysis, Anabolic Markers and Phenotype. PMID: 28177129 Journal: JOURNAL OF CELLULAR PHYSIOLOGY Year: 2017 Reference: J Cell Physiol. 2017 Dec;232(12):3744-3761. doi: 10.1002/jcp.25851. Epub 2017 Apr 27. Impact factor: 4.08 Publication type: Paper in international publication Authors: Garcia-Arumi, Elena, Chacon-Cabrera, Alba, Mateu-Jimenez, Merce, Langohr, Klaus, Fermoselle, Clara, Barreiro, Esther, Yelamos, Jose, Andreu, Antoni L et al. DOI: 10.1002/jcp.25851 Role of Parp Activity in Lung Cancer-induced Cachexia: Effects on Muscle Oxidative Stress, Proteolysis, Anabolic Markers and Phenotype. PMID: 28177129 Journal: JOURNAL OF CELLULAR PHYSIOLOGY Year: 2017 Reference: J Cell Physiol. 2017 Dec;232(12):3744-3761. doi: 10.1002/jcp.25851. Epub 2017 Apr 27. Impact factor: Publication type: Paper in international publication Authors: Andreu, Antoni L; Barreiro, Esther; Chacon-Cabrera, Alba; Fermoselle, Clara; Garcia-Arumi, Elena; Langohr, Klaus; Mateu-Jimenez, Merce; Yelamos, Jose et al. DOI: 10.1002/jcp.25851 Role of total tumour load of sentinel lymph node on survival in early breast cancer patients. PMID: 28254641 Journal: BREAST Year: 2017 Reference: Breast. 2017 Jun;33:8-13. doi: 10.1016/j.breast.2017.02.011. Epub 2017 Feb 28. Impact factor: 2.801 Publication type: Paper in international publication Authors: Peg, Vicente, Sansano, Irene, Vieites, Begona, Bernet, Laia, Cano, Rafael, Cordoba, Alicia, Sancho, Magdalena, Martin, Maria Dolores, Vilardell, Felip, Cazorla, Alicia et al. DOI: 10.1016/j.breast.2017.02.011 Role of total tumour load of sentinel lymph node on survival in early breast cancer patients. PMID: 28254641 Journal: BREAST Year: 2017 Reference: Breast. 2017 Jun;33:8-13. doi: 10.1016/j.breast.2017.02.011. Epub 2017 Feb 28. Impact factor: Publication type: Paper in international publication Authors: Bernet, Laia; Cano, Rafael; Cazorla, Alicia; Cordoba, Alicia; Cortes, Javier; Espinosa-Bravo, Martin; Martin, Maria Dolores; Peg, Vicente; Perez-Garcia, Jose Manuel; Ramon Y Cajal, Santiago et al. DOI: 10.1016/j.breast.2017.02.011 Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. PMID: 28916367 Journal: LANCET Year: 2017 Reference: Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12. Impact factor: 47.831 Publication type: Paper in international publication Authors: Bologna, A, Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew et al. DOI: 10.1016/S0140-6736(17)32440-6 Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. PMID: 28916367 Journal: LANCET Year: 2017 Reference: Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12. Impact factor: Publication type: Paper in international publication Authors: Aghajanian, C; Aghajanian, Carol; Amit, A; Armstrong, D K; Armstrong, Deborah K; Banerjee, S N; Birrer, M J; Bologna, A; Buck, M; Buss, M K et al. DOI: 10.1016/S0140-6736(17)32440-6 Rufinamide in children and adults in routine clinical practice. PMID: 26923380 Journal: ACTA NEUROLOGICA SCANDINAVICA Year: 2017 Reference: Acta Neurol Scand. 2017 Jan;135(1):122-128. doi: 10.1111/ane.12572. Epub 2016 Feb 29. Impact factor: 3.087 Publication type: Paper in international publication Authors: Jaraba, S, Santamarina, E, Miro, J, Toledo, M, Molins, A, Burcet, J, Becerra, J L, Raspall, M, Pico, G, Miravet, E et al. DOI: 10.1111/ane.12572 Rufinamide in children and adults in routine clinical practice. PMID: 26923380 Journal: ACTA NEUROLOGICA SCANDINAVICA Year: 2017 Reference: Acta Neurol Scand. 2017 Jan;135(1):122-128. doi: 10.1111/ane.12572. Epub 2016 Feb 29. Impact factor: Publication type: Paper in international publication Authors: Becerra, J L; Burcet, J; Cano, A; Falip, M; Fernandez, S; Fossas, P; Jaraba, S; Miravet, E; Miro, J; Molins, A et al. DOI: 10.1111/ane.12572 Ruling in and ruling out with elastography in compensated advanced chronic liver disease. PMID: 27015870 Journal: GUT Year: 2017 Reference: Gut. 2017 Jan;66(1):197-198. doi: 10.1136/gutjnl-2016-311775. Epub 2016 Mar 25. Impact factor: 14.921 Publication type: Paper in international publication Authors: Augustin, Salvador, Pons, Monica, Genesca, Joan et al. DOI: 10.1136/gutjnl-2016-311775 Ruling in and ruling out with elastography in compensated advanced chronic liver disease. PMID: 27015870 Journal: GUT Year: 2017 Reference: Gut. 2017 Jan;66(1):197-198. doi: 10.1136/gutjnl-2016-311775. Epub 2016 Mar 25. Impact factor: Publication type: Paper in international publication Authors: Augustin, Salvador; Genesca, Joan; Pons, Monica et al. DOI: 10.1136/gutjnl-2016-311775 Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma. PMID: 29284010 Journal: PLoS One Year: 2017 Reference: PLoS One. 2017 Dec 28;12(12):e0189848. doi: 10.1371/journal.pone.0189848. eCollection 2017. Impact factor: 2.806 Publication type: Paper in international publication Authors: Han, Sae-Won, O'Neil, Bert H, Wallmark, John M, Lorente, David, Elez, Elena, Raimbourg, Judith, Ejadi, Samuel, Piha-Paul, Sarina A, Stein, Mark N, Abdul Razak, Albiruni R et al. DOI: 10.1371/journal.pone.0189848 Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma. PMID: 29284010 Journal: PLoS One Year: 2017 Reference: PLoS One. 2017 Dec 28;12(12):e0189848. doi: 10.1371/journal.pone.0189848. eCollection 2017. Impact factor: Publication type: Paper in international publication Authors: Abdul Razak, Albiruni R; Cohen, Roger B; Dotti, Katia; Ejadi, Samuel; Elez, Elena; Gomez-Roca, Carlos; Gould, Marlena; Han, Sae-Won; Lorente, David; O'Neil, Bert H et al. DOI: 10.1371/journal.pone.0189848 Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials. PMID: 28802814 Journal: The lancet. Gastroenterology & hepatology Year: 2017 Reference: Lancet Gastroenterol Hepatol. 2017 Nov;2(11):814-823. doi: 10.1016/S2468-1253(17)30163-2. Epub 2017 Aug 10. Impact factor: 0 Publication type: Clinical Trials Authors: Lawitz, Eric, Buti, Maria, Vierling, John M, Almasio, Piero L, Bruno, Savino, Ruane, Peter J, Hassanein, Tarek I, Muellhaupt, Beat, Pearlman, Brian, Jancoriene, Ligita et al. DOI: 10.1016/S2468-1253(17)30163-2 Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials. PMID: 28802814 Journal: The lancet. Gastroenterology & hepatology Year: 2017 Reference: Lancet Gastroenterol Hepatol. 2017 Nov;2(11):814-823. doi: 10.1016/S2468-1253(17)30163-2. Epub 2017 Aug 10. Impact factor: Publication type: Clinical Trials Authors: Almasio, Piero L; Barr, Eliav; Bruno, Savino; Buti, Maria; Butterton, Joan R; Dutko, Frank J; Fernsler, Doreen; Gao, Wei; Grandhi, Anjana; Hassanein, Tarek I et al. DOI: 10.1016/S2468-1253(17)30163-2 Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials. PMID: 28802816 Journal: The lancet. Gastroenterology & hepatology Year: 2017 Reference: Lancet Gastroenterol Hepatol. 2017 Nov;2(11):805-813. doi: 10.1016/S2468-1253(17)30159-0. Epub 2017 Aug 10. Impact factor: 0 Publication type: Clinical Trials Authors: Su, Feng-Hsiu, Wan, Shuyan, Zeng, Zhen, Chen, Huei-Ling, Dutko, Frank J, Nguyen, Bach-Yen T, Wahl, Janice, Robertson, Michael N, Barr, Eliav, Yeh, Wendy W et al. DOI: 10.1016/S2468-1253(17)30159-0 Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials. PMID: 28802816 Journal: The lancet. Gastroenterology & hepatology Year: 2017 Reference: Lancet Gastroenterol Hepatol. 2017 Nov;2(11):805-813. doi: 10.1016/S2468-1253(17)30159-0. Epub 2017 Aug 10. Impact factor: Publication type: Clinical Trials Authors: Agarwal, Kosh; Barr, Eliav; Ben-Ari, Ziv; Butterton, Joan R; Chen, Huei-Ling; Dutko, Frank J; Esteban, Rafael; Fernsler, Doreen; Fitzgerald, Brian; Foster, Graham R et al. DOI: 10.1016/S2468-1253(17)30159-0 Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. PMID: 29066163 Journal: LANCET NEUROLOGY Year: 2017 Reference: Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Impact factor: 26.284 Publication type: Paper in international publication Authors: D'Hondt, Ann, Garcia, Alejandra Dalila, Lamont, Phillipa, Leong, Wai-Kuen, Boterhoven, Heidi, Fyfe, Beverly, Roberts, Leslie, Jasinarachchi, Mahi, Willlems, Natasha, Wanschitz, Julia et al. DOI: 10.1016/S1474-4422(17)30369-1 Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. PMID: 29066163 Journal: LANCET NEUROLOGY Year: 2017 Reference: Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Impact factor: Publication type: Paper in international publication Authors: Abramov, Vladislav; Acar, Nazire Pinar; Agopian, Eliz; Agriesti, Julie; Akhter, Salma; Akiyama, Tetsuya; Alberti Aguilo, Maria; Alboini, Paolo Emilio; Alcon, Karan; Alsharabati, Mohammad et al. DOI: 10.1016/S1474-4422(17)30369-1 Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. PMID: 28229893 Journal: LANCET NEUROLOGY Year: 2017 Reference: Lancet Neurol. 2017 Mar;16(3):217-226. doi: 10.1016/S1474-4422(16)30357-X. Epub 2017 Feb 15. Impact factor: 26.284 Publication type: Paper in international publication Authors: Elkins, Jacob, Veltkamp, Roland, Montaner, Joan, Johnston, S Claiborne, Singhal, Aneesh B, Becker, Kyra, Lansberg, Maarten G, Tang, Weihua, Chang, Ih, Muralidharan, Kumar et al. DOI: 10.1016/S1474-4422(16)30357-X Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. PMID: 28229893 Journal: LANCET NEUROLOGY Year: 2017 Reference: Lancet Neurol. 2017 Mar;16(3):217-226. doi: 10.1016/S1474-4422(16)30357-X. Epub 2017 Feb 15. Impact factor: Publication type: Paper in international publication Authors: Becker, Kyra; Chang, Ih; Elkind, Mitchell S V; Elkins, Jacob; Gheuens, Sarah; Johnston, S Claiborne; Lansberg, Maarten G; Mehta, Lahar; Montaner, Joan; Muralidharan, Kumar et al. DOI: 10.1016/S1474-4422(16)30357-X Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon gamma release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. PMID: 28159608 Journal: Lancet Respiratory Medicine Year: 2017 Reference: Lancet Respir Med. 2017 Apr;5(4):259-268. doi: 10.1016/S2213-2600(16)30436-2. Epub 2017 Feb 1. Impact factor: 19.287 Publication type: Paper in international publication Authors: Orcau, Angels, Andersen, Peter, Cayla, Joan A, Roldan, Llanos, Miro, Jose M, Moreno, Antonio, Ruhwald, Morten, Aggerbeck, Henrik, Gallardo, Rafael Vazquez, Hoff, Soren T et al. DOI: 10.1016/S2213-2600(16)30436-2 Pagination First page « First Previous page ‹ Previous … Page 1035 Page 1036 Page 1037 Page 1038 Current page 1039 Page 1040 Page 1041 Page 1042 Page 1043 … Next page Next › Last page Last »
